Luzerner Kantonsspital account plan
Compassionate patient-centered hospital care
At a glance
Luzerner Kantonsspital (LUKS Gruppe) is a cantonal hospital group in Central Switzerland with 8,628 employees and CHF 1.341 bn revenue in 2025.
LUKS Gruppe, whose legal entity Luzerner Kantonsspital AG is 100% owned by the Canton of Lucerne, provides basic to highly specialised care for the Canton of Lucerne and Central Switzerland. It runs hospitals in Luzern (a university teaching and research hospital), Sursee and Wolhusen, and holds 60% of Spital Nidwalden in Stans. In 2025 revenue was CHF 1.341 bn (+7.2%) and the annual result CHF 42.2 m, after CHF -24.6 m in 2024, with 8,628 employees, 51,572 inpatients and 970,542 outpatient contacts. Florian Aschbrenner has been CEO since 01.04.2025 and Dr. med. Martin Nufer chairs the board.
Business units
LUKS Luzern
6,227 employees, about 72% of group staff (computed)The main campus and university teaching hospital, home to the Kinderspital Zentralschweiz, the Frauenklinik and specialist clinics and institutes, with 680,272 outpatient contacts and 30,527 inpatients in 2025. The new Kinderspital and Frauenklinik opened on 16 September 2026.
LUKS Sursee
908 employees, about 10.5% of group staff (computed)Regional hospital providing 24-hour emergency care since late 2024, with an ambulatory surgery centre; a new hospital in Schenkon (project "Feld und Flur") depends on municipal votes in 2027 and is under strategic review.
LUKS Wolhusen
706 employees, about 8.2% of group staff (computed)Regional hospital with a rehabilitation centre; a new hospital is under construction, with opening scheduled for 2028.
Spital Nidwalden (Stans)
671 employees, about 7.8% of group staff (computed)Owned 60% by LUKS AG and 40% by the Canton of Nidwalden; its loss narrowed from CHF 8.97 m in 2024 to CHF 2.9 m in 2025. A complete new hospital at a new site is being evaluated.
Luzerner Höhenklinik Montana
116 employees, about 1.3% of group staff (computed)Rehabilitation clinic in Montana VS, sold to Berner Klinik Montana with effect from 01.01.2026 at net asset value.
Strategic priorities
- Reaching the financial targets
- The group targets an EBITDA margin of at least 10% and an equity ratio of at least 50%; in 2025 the EBITDA margin was 8.6% and the equity ratio 45.1%.
- Strategy process and transformation
- A comprehensive strategy process started in early summer 2025 and runs through 2026, covering cross-site organisation, the service portfolio and financial steering.
- Shift to outpatient care
- About 40% of medical revenue comes from outpatient care and the share is rising; the group is expanding outpatient processes such as the ambulatory surgery centre in Sursee.
- Integrating Kantonsspital Obwalden
- Kantonsspital Obwalden joins the group in 2028/2029, with harmonisation of clinical and operational processes as the focus.
- Digital and clinical innovation
- Standardise the Epic clinical information system (LUKiS), extend the Virtual Care Unit, push robotics in surgery and diagnostics, and pursue the net-zero target and lean processes.
Investments and deals
- Kinderspital and Frauenklinik Luzern
- Opened on 16 September 2026 with moves in October 2026; forecast investment is about CHF 202 m for the Kinderspital and about CHF 94 m for the Frauenklinik, including equipment.
- New hospital in Wolhusen
- Shell completed in September 2025, interior fit-out under way and opening scheduled for 2028.
- Review of large building projects
- The board is reassessing the Sursee new build and the Ambulantes Zentrum and Stationäres Zentrum in Luzern for size, focus and investment volume.
- Capital spending and financing
- TCHF 158,325 was added to assets under construction in 2025; long-term debt of CHF 386 m includes a 2.10% CHF 150 m Green Bond due 2034.
- Divestments
- Sold Luzerner Höhenklinik Montana (01.01.2026), the 40% stake in Medbase Zentralschweiz AG and the stake in Bluespace Ventures AG.
Challenges and risks
- Infrastructure financing burden
- Leaders say the positive 2025 result should not hide the financial challenges from the planned infrastructure investments, which raise borrowing.
- Outpatient tariffs
- Delivering outpatient care in structures built mainly for inpatients causes efficiency losses that current tariffs hardly cover.
- Skilled staff shortage and demographics
- Population growth and ageing, the skilled staff shortage and cost pressure are named as structural pressures.
- Leadership turnover and internal mood
- The CMO, CIO and two COOs left during 2025, and the CEO acknowledged in early 2026 that internal communication about the transformation had not been enough.
What leadership says
“Die bisherige Kommunikation reicht offenbar nicht aus. Es ist enorm wichtig, die Mitarbeitenden noch besser abzuholen”
“Die eingeleiteten Massnahmen entfalten Wirkung. Gleichzeitig bleiben die strukturellen Rahmenbedingungen anspruchsvoll”
“Das Ergebnis 2025 zeigt, dass wir auf dem richtigen Weg sind”
“Ein Gebäude allein macht noch kein Spital. Entscheidend sind die Menschen, die darin arbeiten”
Where a supplier can help
- Outpatient process efficiency
- Tied to the outpatient shift: scheduling, patient flow and day-surgery solutions address the efficiency losses of running outpatient care in inpatient structures.
- Commissioning new buildings
- Tied to the Kinderspital/Frauenklinik opening and the Wolhusen build: medical equipment, logistics and facilities services fit the commissioning and transfer of operations.
- Epic and virtual care
- Tied to the LUKiS standardisation and Virtual Care Unit priorities: integration, analytics and remote monitoring offers support the digital roadmap and the Obwalden integration.
- Change management and staff retention
- Tied to the transformation and the skilled staff shortage: internal communication, workforce and retention offers match the CEO's stated need to bring staff along.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Luzerner Kantonsspital?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- LUKS Gruppe Jahresbericht 2025
- LUKS Gruppe (Luzerner Kantonsspital AG) is a cantonal hospital group in Central Switzerland. The Canton of Lucerne owns 100% of Luzerner Kantonsspital AG, which holds 60% of Spital Nidwalden AG (Canton of Nidwalden 40%). Sites are Luzern (a university teaching and research hospital), Sursee, Wolhusen and Stans (Spital Nidwalden). Luzerner Höhenklinik Montana was sold with effect from 01.01.2026.
- FY2025: revenue CHF 1.341 bn (+7.2%), annual result CHF 42.2 m after CHF -24.6 m in 2024; operating expenses +5.3%; equity ratio 45.1%.
- Scale: 8,628 employees, 960 in apprenticeships or training, 522 doctors in specialist training, 51,572 inpatients, 970,542 outpatient contacts, 839 operated beds, 55 operating and delivery rooms, 3,910 births, 21,752 ambulance missions.
- Strategy targets: a group EBITDA margin of at least 10% and an equity ratio of at least 50%. A new strategy process, started by the board and management in early summer 2025, runs through 2026 and is the basis for a transformation.
- Large building programme: the new Kinderspital/Frauenklinik in Luzern was due to open in autumn 2026, Wolhusen in 2028 and Sursee/Schenkon ("Feld und Flur" project). The board has started a review of the large building projects, including the Ambulantes Zentrum and Stationäres Zentrum in Luzern.
- Kantonsspital Obwalden is to join the group in 2028/2029. Group-wide quality indicators start on 01.01.2026. Priorities are the Epic clinical information system (LUKiS), the Virtual Care Unit, robotics in surgery and diagnostics, and a net-zero target.
- Leadership change: Florian Aschbrenner became CEO on 01.04.2025 (Benno Fuchs retired) and Dr. med. Martin Nufer chairs the board. In November 2025 the group named Rebekka Hatzung COO and deputy CEO and Dr. med. Patrick Aepli CMO. The CMO, CIO and two COOs left during 2025.
- Pressures named by the leaders: population growth and ageing, the shift to outpatient care, high cost pressure, the shortage of skilled staff, and the large financial burden of the planned infrastructure investments.
- LUKS Gruppe Finanzbericht 2025 (consolidated financial statements, Swiss GAAP FER)
- Audited consolidated financial statements of LUKS Gruppe for 2025 under Swiss GAAP FER (auditor KPMG; approved by the board on 20 March 2026).
- Operating income TCHF 1,341,208 (+7.2%); EBITDA TCHF 114,957 (2024: TCHF 34,021); EBIT TCHF 47,817; annual result TCHF 42,202 (2024: TCHF -24,606).
- EBITDA margin 8.6% in the key-figures table (8.5% in the commentary), still below the 10% strategic target.
- Net revenue by segment: inpatient TCHF 710,285, outpatient TCHF 476,163, staff and third parties TCHF 107,929. Outpatient care is about 40% of medical revenue, which is economically challenging under current tariffs.
- By company: LUKS Spitalbetriebe AG operating income TCHF 1,225,863 (EBITDA 5.2%); Spital Nidwalden AG TCHF 99,775 (EBITDA -1.6%, result TCHF -2,860); Luzerner Höhenklinik Montana AG TCHF 13,276; LUKS Immobilien AG TCHF 49,928.
- Personnel expense TCHF 803,715, including the release of a CHF 12.3 m LUPK provision and a CHF 6 m profit-sharing provision. Medical supplies TCHF 275,858.
- Investment: TCHF 158,325 added to assets under construction; operating cash flow TCHF 163,164. Unbilled patient services fell about 30%, to TCHF 118,544.
- Debt: CHF 386 m long-term, including a 0.625% CHF 150 m bond due 2028 and a 2.10% CHF 150 m Green Bond due 2034. Equity ratio 45.1% in the text (45.0% in the table).
- Outlook: the new Kinderspital/Frauenklinik opens in autumn 2026, Wolhusen is on plan, and the Sursee and Luzern Ambulantes Zentrum projects are under strategic review. Höhenklinik Montana was sold retroactively to 01.01.2026 at net asset value.
- Hohe Nachfrage und Kostendisziplin: LUKS Gruppe 2025 mit positivem Ergebnis (results press release)
- LUKS Gruppe press release on the 2025 results, published 30 April 2026.
- Revenue up 7.2% to CHF 1.341 bn; expenses up only 0.7%; profit CHF 42.2 m; equity ratio 45.1% (2024: 42.8%).
- More than 51,500 inpatients (+2.4%) and about 970,000 patient contacts (+4.8%), beating the 2024 record again.
- Spital Nidwalden narrowed its loss from CHF 8.97 m in 2024 to CHF 2.9 m in 2025, through revenue increases and targeted cost optimisation.
- About 40% of medical revenue now comes from outpatient care, and the share is rising. Delivering outpatient care inside structures built mainly for inpatients causes efficiency losses and is hard to cover with current tariffs; the group is expanding outpatient processes such as the ambulatory surgery centre in Sursee.
- Chair Martin Nufer presents 2025 as one step: the board started a comprehensive strategy process in early summer 2025 covering cross-site organisation, the service portfolio and financial steering.
- Pressures named: the shift to outpatient care, demographic change, the shortage of skilled staff, digitalisation and high investment needs.
- LUKS eröffnet neues Kinderspital und neue Frauenklinik (press release)
- LUKS press release of 16 September 2026: the new Kinderspital Zentralschweiz and the new Frauenklinik in Luzern have officially opened, with moves into the buildings in October 2026.
- The project combines paediatrics, obstetrics and gynaecology on one site, with a new Perinatalzentrum (perinatal centre), single rooms and family-centred care models.
- Current forecast investment: about CHF 202 m for the Kinderspital and about CHF 94 m for the Frauenklinik, both including equipment. Construction started in 2020.
- The cost increase over the first estimates is put down to inflation, the higher VAT rate, extra operating and patient-safety requirements, and more precise estimates as planning progressed.
- The Stiftung Zukunft Kinderspital Zentralschweiz, founded in 2020, funded extras beyond the regular service mandate.
- Chair Martin Nufer calls the decision to co-locate the two clinics "visionär, mutig und richtig" (visionary, bold and right). CEO Florian Aschbrenner stresses that people, not buildings, make a hospital.
- Jetzt redet Florian Aschbrenner (Medinside on the CEO's first interview with the Luzerner Zeitung)
- Medinside report (2 February 2026) on CEO Florian Aschbrenner's first interview, given to the Luzerner Zeitung about ten months after he took office in April 2025.
- Context: after several unexplained departures from the executive board, including CMO Katrin Hoffmann, staff discontent grew. On 17 January 2026 the Luzerner Zeitung quoted insiders saying the mood was "fürchterlich" (terrible).
- Two chief physicians, Stephan Bohlhalter and Oliver Fuchs (allergology), disputed that account in readers' letters.
- Aschbrenner says the criticism does not leave him cold and that he takes it very seriously, but he does not perceive the atmosphere described.
- His conclusion: internal communication has not been enough, and staff must be brought along better; the group will report more intensively and regularly on the transformation process.
- The 43-year-old describes his first ten months as "superpositiv" and says he was received warmly and openly.
- Sales takeaway: a new CEO driving a transformation under internal scrutiny, with communication about change as a stated priority.
Questions about Luzerner Kantonsspital
What is Luzerner Kantonsspital?
LUKS Gruppe is a hospital group owned by the Canton of Lucerne, running hospitals in Luzern, Sursee and Wolhusen and a 60% stake in Spital Nidwalden.
What is LUKS Gruppe's revenue?
Revenue was CHF 1.341 bn in 2025, up 7.2%, with an annual result of CHF 42.2 m.
How many employees does LUKS have?
8,628 employees in 2025, including 960 people in apprenticeships or training.
Who leads Luzerner Kantonsspital?
Florian Aschbrenner has been CEO since 01.04.2025, and Dr. med. Martin Nufer chairs the board.
What is LUKS's strategy?
A strategy process running through 2026 aims at an EBITDA margin of at least 10%, more outpatient care, digital and robotic innovation and the integration of Kantonsspital Obwalden.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)